サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1519302

GABAサプリメントの世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- 形態別、流通チャネル別、国別

GABA Supplements Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

出版日
ページ情報
英文 250 Pages
納期
2～5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
GABAサプリメントの世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- 形態別、流通チャネル別、国別
出版日: 2024年07月15日
発行: Fairfield Market Research
ページ情報: 英文 250 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

GABAサプリメントの市場規模は、2024年の4,531万米ドルから2031年には6,932万米ドルに成長すると予測されており、CAGRは6%と見込まれています。この成長は、リラクゼーションを助け、睡眠の質を高め、不安を軽減する栄養補助食品に対する消費者の意識と需要の高まりを浮き彫りにしています。カプセルは収益面で市場を独占し、今後数年間で大幅な成長が見込まれます。

いくつかの要因がGABAサプリメント市場の成長を促進しています。このサプリメントは、脳のリラクゼーションを促進し、ストレスレベルを下げ、睡眠の質を改善し、不安やホルモンの過敏性を軽減するなど、数多くの健康上の利点を提供します。ストレス、不安、睡眠障害が一般的な今日の目まぐるしい環境では、こうしたメリットは特に貴重です。

Sleep Foundationによると、世界ではかなりの数の成人が不眠症に苦しんでおり、慢性不眠症は人口の大部分に影響を及ぼしています。日本、米国、英国、韓国などの国々では、睡眠に対する不満のレベルが高いことが報告されており、リラックス効果や睡眠改善効果で知られるGABAサプリメントにとって大きなチャンスとなっています。

COVID-19の大流行は世界のメンタルヘルスに大きな影響を与え、不安やうつ病の顕著な増加をもたらしています。この急増が、リラックスを促し不安を軽減する栄養補助食品の需要を押し上げています。神経伝達物質の機能をサポートすることで知られるGABAサプリメントは、こうしたメンタルヘルス上の懸念に対する効果的な解決策として人気を集めています。

当レポートでは、世界のGABAサプリメント市場について調査し、市場の概要とともに、形態別、流通チャネル別、国別動向、および市場に参入する企業の競合動向などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の定義とセグメンテーション
  • 市場力学
  • バリューチェーン分析
  • ポーターのファイブフォース分析
  • COVID-19の影響分析
  • ウクライナ・ロシア紛争の影響
  • 経済概要
  • PESTLE分析

第3章 世界のGABAサプリメント市場の見通し、2019年～2031年

  • 世界のGABAサプリメント市場の見通し、形態別、金額別（100万米ドル）、2019年～2031年
  • 世界のGABAサプリメント市場の見通し、流通チャネル別、金額（100万米ドル）、2019年～2031年
  • 世界のGABAサプリメント市場の見通し、地域別、金額（100万米ドル）、2019年～2031年

第4章 北米のGABAサプリメント市場の見通し、2019年～2031年

第5章 欧州のGABAサプリメント市場の見通し、2019年～2031年

第6章 アジア太平洋のGABAサプリメント市場の見通し、2019年～2031年

第7章 ラテンアメリカのGABAサプリメント市場の見通し、2019年～2031年

第8章 中東・アフリカのGABAサプリメント市場の見通し、2019年～2031年

第9章 競合情勢

  • メーカー別と流通チャネル別のヒートマップ
  • 企業市場シェア分析、2024年
  • 競合ダッシュボード
  • 企業プロファイル
    • Merz Inc
    • Now Foods
    • Horbaach
    • Pure Encapsulations
    • Thorne
    • VITANICA
    • NutraBio
    • Country Life
    • Integrative Therapeutics
    • Solgar
    • Nusa Pure

第10章 付録

目次

The GABA supplements market is poised for significant expansion, with projections indicating it will grow from $45.31 million in 2024 to $69.32 million by 2031, reflecting a CAGR of 6%. This growth highlights the increasing consumer awareness and demand for dietary supplements that aid relaxation, enhance sleep quality, and reduce anxiety. Capsules are expected to dominate the market in terms of revenue generation, showing substantial growth prospects in the coming years.

Key Factors Driving Market Growth

Several factors are driving the growth of the GABA supplements market. These supplements offer numerous health benefits, such as promoting brain relaxation, lowering stress levels, improving sleep quality, and reducing anxiety and hormonal irritability. In today's fast-paced environment, where stress, anxiety, and sleep disorders are common, these benefits are particularly valuable.

According to the Sleep Foundation, a significant number of adults globally suffer from insomnia, with chronic insomnia affecting a large portion of the population. Countries like Japan, the United States, the United Kingdom, and South Korea report high levels of sleep dissatisfaction, creating a significant opportunity for GABA supplements known for their relaxation and sleep-enhancing properties.

Impact of Covid-19 on Mental Health

The Covid-19 pandemic has significantly impacted mental health worldwide, leading to a marked increase in anxiety and depression. This surge has driven the demand for dietary supplements that promote relaxation and reduce anxiety. GABA supplements, known for supporting neurotransmitter function, are gaining popularity as effective solutions for these mental health concerns.

Addressing PMDD and Hypertension

Premenstrual dysphoric disorder (PMDD) affects many women, causing anxiety, depression, mood swings, and irritability. GABA supplements can help alleviate these symptoms, making them an attractive option for those seeking mental wellness and reduced inflammation.

Hypertension is another growing concern globally, with many adults affected. Studies indicate that GABA supplements can significantly lower blood pressure, offering a potential dietary solution for managing hypertension.

Supporting Underlying Medical Conditions

Individuals with conditions such as Parkinson's disease, hyperactivity disorder, and seizure disorders may have lower GABA levels. In these cases, GABA supplements can provide additional support by inducing calming effects and reducing anxiety.

Regional Market Insights

North America

North America is a leading market for GABA supplements, driven by high levels of chronic stress and anxiety and a significant portion of the population experiencing sleep-related issues.

United States

Anxiety disorders are among the most common mental health issues in the United States, affecting millions of adults annually. Many individuals prefer dietary supplements over traditional treatments to manage their anxiety, presenting a growth opportunity for GABA supplements.

United Kingdom

The United Kingdom has seen a rise in anxiety and depression, especially post-Covid-19. This has led to increased consumption of sleeping pills and anxiety medications, highlighting the need for non-harmful alternatives like GABA supplements.

Japan

Japan faces significant sleep disorder issues, with a large percentage of the population suffering from insomnia. This ongoing problem is driving the demand for GABA dietary supplements as a solution for better sleep and relaxation.

China

China's high prevalence of sleep disorders affects millions of people, influencing the demand for dietary supplements like GABA that promote better sleep and overall wellness.

South Korea

South Korea experiences notable stress and sleep-related issues, contributing to the demand for GABA supplements. The country's focus on skincare and wellness aligns with the benefits of GABA supplements, making them a popular choice for promoting beauty sleep and reducing stress.

Market Form and Competitive Analysis

GABA supplements come in various forms, including capsules, lozenges, powder, and gummies, with capsules projected to witness significant growth due to their convenience and efficacy.

Key players in the GABA supplements market include Now Foods, Horbaach, Pure Encapsulations, Thorne, Vitanica, Nutrabio, Country Life, Integrative Therapeutics, Solgar, and Nusa Pure. These companies offer a wide range of GABA supplements and provide resources such as stress-measuring tests and FAQs on their websites to assist consumers in selecting the best products for their needs.

Market Segmentation

By Form:

  • Capsules
  • Lozenges
  • Powder
  • Gummies

By Distribution Channel:

  • Online Stores
  • Pharmacies
  • Supermarkets
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global GABA Supplements Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2024
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global GABA Supplements Market Outlook, 2019-2031

  • 3.1. Global GABA Supplements Market Outlook, by Form, Value (US$ Mn), 2019-2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Capsules
      • 3.1.1.2. Lozenges
      • 3.1.1.3. Powder
      • 3.1.1.4. Gummies
  • 3.2. Global GABA Supplements Market Outlook, by Distribution Channel, Value (US$ Mn), 2019-2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Online Stores
      • 3.2.1.2. Pharmacies
      • 3.2.1.3. Supermarkets
      • 3.2.1.4. Others
  • 3.3. Global GABA Supplements Market Outlook, by Region, Value (US$ Mn), 2019-2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. North America
      • 3.3.1.2. Europe
      • 3.3.1.3. Asia Pacific
      • 3.3.1.4. Latin America
      • 3.3.1.5. Middle East & Africa

4. North America GABA Supplements Market Outlook, 2019-2031

  • 4.1. North America GABA Supplements Market Outlook, by Form, Value (US$ Mn), 2019-2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Capsules
      • 4.1.1.2. Lozenges
      • 4.1.1.3. Powder
      • 4.1.1.4. Gummies
  • 4.2. North America GABA Supplements Market Outlook, by Distribution Channel, Value (US$ Mn), 2019-2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Online Stores
      • 4.2.1.2. Pharmacies
      • 4.2.1.3. Supermarkets
      • 4.2.1.4. Others
  • 4.3. North America GABA Supplements Market Outlook, by Country, Value (US$ Mn), 2019-2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. U.S. GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
      • 4.3.1.2. U.S. GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
      • 4.3.1.3. Canada GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
      • 4.3.1.4. Canada GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031

5. Europe GABA Supplements Market Outlook, 2019-2031

  • 5.1. North America GABA Supplements Market Outlook, by Form, Value (US$ Mn), 2019-2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Capsules
      • 5.1.1.2. Lozenges
      • 5.1.1.3. Powder
      • 5.1.1.4. Gummies
  • 5.2. Europe GABA Supplements Market Outlook, by Distribution Channel, Value (US$ Mn), 2019-2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Online Stores
      • 5.2.1.2. Pharmacies
      • 5.2.1.3. Supermarkets
      • 5.2.1.4. Others
  • 5.3. Europe GABA Supplements Market Outlook, by Country, Value (US$ Mn), 2019-2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Germany GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
      • 5.3.1.2. Germany GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
      • 5.3.1.3. U.K. GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
      • 5.3.1.4. U.K. GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
      • 5.3.1.5. France GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
      • 5.3.1.6. France GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
      • 5.3.1.7. Italy GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
      • 5.3.1.8. Italy GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
      • 5.3.1.9. Turkey GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
      • 5.3.1.10. Turkey GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
      • 5.3.1.11. Russia GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
      • 5.3.1.12. Russia GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
      • 5.3.1.13. Rest of Europe GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
      • 5.3.1.14. Rest of Europe GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031

6. Asia Pacific GABA Supplements Market Outlook, 2019-2031

  • 6.1. Asia Pacific GABA Supplements Market Outlook, by Form, Value (US$ Mn), 2019-2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Capsules
      • 6.1.1.2. Lozenges
      • 6.1.1.3. Powder
      • 6.1.1.4. Gummies
  • 6.2. Asia Pacific GABA Supplements Market Outlook, by Distribution Channel, Value (US$ Mn), 2019-2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Online Stores
      • 6.2.1.2. Pharmacies
      • 6.2.1.3. Supermarkets
      • 6.2.1.4. Others
  • 6.3. Asia Pacific GABA Supplements Market Outlook, by Country, Value (US$ Mn), 2019-2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. China GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
      • 6.3.1.2. China GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
      • 6.3.1.3. Japan GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
      • 6.3.1.4. Japan GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
      • 6.3.1.5. South Korea GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
      • 6.3.1.6. South Korea GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
      • 6.3.1.7. India GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
      • 6.3.1.8. India GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
      • 6.3.1.9. Southeast Asia GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
      • 6.3.1.10. Southeast Asia GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
      • 6.3.1.11. Rest of Asia Pacific GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
      • 6.3.1.12. Rest of Asia Pacific GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031

7. Latin America GABA Supplements Market Outlook, 2019-2031

  • 7.1. Latin America GABA Supplements Market Outlook, by Form, Value (US$ Mn), 2019-2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Capsules
      • 7.1.1.2. Lozenges
      • 7.1.1.3. Powder
      • 7.1.1.4. Gummies
  • 7.2. Latin America GABA Supplements Market Outlook, by Distribution Channel, Value (US$ Mn), 2019-2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Online Stores
      • 7.2.1.2. Pharmacies
      • 7.2.1.3. Supermarkets
      • 7.2.1.4. Others
  • 7.3. Latin America GABA Supplements Market Outlook, by Country, Value (US$ Mn), 2019-2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Brazil GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
      • 7.3.1.2. Brazil GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
      • 7.3.1.3. Mexico GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
      • 7.3.1.4. Mexico GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
      • 7.3.1.5. Argentina GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
      • 7.3.1.6. Argentina GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
      • 7.3.1.7. Rest of Latin America GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
      • 7.3.1.8. Rest of Latin America GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031

8. Middle East & Africa GABA Supplements Market Outlook, 2019-2031

  • 8.1. Middle East & Africa GABA Supplements Market Outlook, by Form, Value (US$ Mn), 2019-2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Capsules
      • 8.1.1.2. Lozenges
      • 8.1.1.3. Powder
      • 8.1.1.4. Gummies
  • 8.2. Middle East & Africa GABA Supplements Market Outlook, by Distribution Channel, Value (US$ Mn), 2019-2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Online Stores
      • 8.2.1.2. Pharmacies
      • 8.2.1.3. Supermarkets
      • 8.2.1.4. Others
  • 8.3. Middle East & Africa GABA Supplements Market Outlook, by Country, Value (US$ Mn), 2019-2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. GCC GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
      • 8.3.1.2. GCC GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
      • 8.3.1.3. South Africa GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
      • 8.3.1.4. South Africa GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
      • 8.3.1.5. Egypt GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
      • 8.3.1.6. Egypt GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
      • 8.3.1.7. Nigeria GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
      • 8.3.1.8. Nigeria GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
      • 8.3.1.9. Rest of Middle East & Africa GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
      • 8.3.1.10. Rest of Middle East & Africa GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031

9. Competitive Landscape

  • 9.1. Manufacturer vs by Distribution Channel Heatmap
  • 9.2. Company Market Share Analysis, 2024
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Merz Inc
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. Now Foods
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Product Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. Horbaach
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Product Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. Pure Encapsulations
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Product Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. Thorne
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Product Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. VITANICA
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. NutraBio
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Product Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. Country Life
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Product Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development
    • 9.4.9. Integrative Therapeutics
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Product Portfolio
      • 9.4.9.3. Financial Overview
      • 9.4.9.4. Business Strategies and Development
    • 9.4.10. Solgar
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Product Portfolio
      • 9.4.10.3. Financial Overview
      • 9.4.10.4. Business Strategies and Development
    • 9.4.11. Nusa Pure
      • 9.4.11.1. Company Overview
      • 9.4.11.2. Product Portfolio
      • 9.4.11.3. Financial Overview
      • 9.4.11.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations